Algert Global LLC Kezar Life Sciences, Inc. Transaction History

Algert Global LLC

  • $3.72 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$2.31 - $3.06 $34,308 - $45,447
-14,852 Reduced 20.56%
57,390 $141,000
Q1 2023

May 12, 2023
BUY
$3.13 - $7.31 $6,795 - $15,870
2,171 Added 3.1%
72,242 $226,000
Q4 2022

Feb 13, 2023
BUY
$6.39 - $8.8 $213,170 - $293,568
33,360 Added 90.87%
70,071 $493,000
Q3 2022

Nov 15, 2022
BUY
$7.99 - $10.75 $293,320 - $394,643
36,711 New
36,711 $316,000

Others Institutions Holding KZR

# of Institutions
61
Shares Held
38.4M
Call Options Held
13.8K
Put Options Held
600
View Full List

About Kezar Life Sciences, Inc.

KZR Quotes by TradingView
  • Ticker KZR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,369,504
  • Market Cap $446M
  • Description
  • Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...
More about KZR
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email